- Home
- IMMP vs NPCT Comparison
IMMP vs NPCT Comparison
Compare IMMP & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- NPCT
- Stock Information
- Founded
- IMMP 1987
- NPCT 2020
- Country
- IMMP Australia
- NPCT United States
- Employees
- IMMP N/A
- NPCT N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- IMMP Health Care
- NPCT Finance
- Exchange
- IMMP Nasdaq
- NPCT Nasdaq
- Market Cap
- IMMP 211.1M
- NPCT 284.1M
- IPO Year
- IMMP N/A
- NPCT N/A
- Fundamental
- Price
- IMMP $1.86
- NPCT $10.37
- Analyst Decision
- IMMP Buy
- NPCT
- Analyst Count
- IMMP 2
- NPCT 0
- Target Price
- IMMP $8.50
- NPCT N/A
- AVG Volume (30 Days)
- IMMP 648.0K
- NPCT 107.1K
- Earning Date
- IMMP 05-16-2025
- NPCT 01-01-0001
- Dividend Yield
- IMMP N/A
- NPCT 9.82%
- EPS Growth
- IMMP N/A
- NPCT N/A
- EPS
- IMMP N/A
- NPCT N/A
- Revenue
- IMMP $3,019,249.00
- NPCT N/A
- Revenue This Year
- IMMP $11.25
- NPCT N/A
- Revenue Next Year
- IMMP $10.22
- NPCT N/A
- P/E Ratio
- IMMP N/A
- NPCT N/A
- Revenue Growth
- IMMP 24.11
- NPCT N/A
- 52 Week Low
- IMMP $1.32
- NPCT $8.58
- 52 Week High
- IMMP $3.34
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- NPCT 56.04
- Support Level
- IMMP $1.44
- NPCT $10.20
- Resistance Level
- IMMP $2.71
- NPCT $10.43
- Average True Range (ATR)
- IMMP 0.17
- NPCT 0.12
- MACD
- IMMP 0.05
- NPCT 0.05
- Stochastic Oscillator
- IMMP 29.75
- NPCT 90.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.